VBI Vaccines Company Insiders
| VBIVQ Stock | 0.0005 0.00 0.000004% |
VBI Vaccines employs about 131 people. The company is managed by 9 executives with a total tenure of roughly 306 years, averaging almost 34.0 years of service per executive, having 14.56 employees per reported executive. Discussion of VBI Vaccines' management performance can provide insight into the enterprise performance.
VBI |
VBI Vaccines Workforce Comparison
VBI Vaccines is rated first in number of employees category among its peers. The total workforce of Biotechnology industry is at this time estimated at about 35,113. VBI Vaccines adds roughly 131 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
VBI Vaccines Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. VBI Vaccines Price Series Summation is a cross summation of VBI Vaccines price series and its benchmark/peer.
VBI Vaccines Notable Stakeholders
A VBI Vaccines stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as VBI Vaccines often face trade-offs trying to please all of them. VBI Vaccines' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting VBI Vaccines' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Jeffery FCMA | CEO President | Profile | |
| Nell Beattie | Head CFO | Profile | |
| Nicole Anderson | Director Relations | Profile | |
| FRCPC MD | Chief Officer | Profile | |
| Avi Mazaltov | Global SciVac | Profile | |
| Misha Nossov | Senior Europe | Profile | |
| David Anderson | Chief Officer | Profile | |
| Athena Kartsaklis | Chief Finance | Profile | |
| John Dillman | Chief Officer | Profile |
About VBI Vaccines Management Performance
The success or failure of an entity such as VBI Vaccines often depends on how effective the management is. VBI Vaccines management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of VBI management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the VBI management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
VBI Vaccines is entity of United States. It is traded as Stock on NASDAQ exchange.
VBI Vaccines Workforce Analysis
Traditionally, organizations such as VBI Vaccines use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare VBI Vaccines within its industry.VBI Vaccines Manpower Efficiency
Return on VBI Vaccines Manpower
| Revenue Per Employee | 66.3K | |
| Revenue Per Executive | 964.7K | |
| Net Loss Per Employee | 708.7K | |
| Net Loss Per Executive | 10.3M |
Additional Tools for VBI Stock Analysis
When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.